Where does Semnur Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Semnur Pharmaceuticals, Inc. ranks #33,204 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Semnur Pharmaceuticals, Inc. hold?

Semnur Pharmaceuticals, Inc. holds 8 US utility patents granted between 2017 and 2025, spanning 2 technology areas.

What is Semnur Pharmaceuticals, Inc.'s Innovation Score?

Semnur Pharmaceuticals, Inc. has an Innovation Score of 31.8 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Semnur Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Semnur Pharmaceuticals, Inc.'s recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Semnur Pharmaceuticals, Inc.'s patents?

Semnur Pharmaceuticals, Inc.'s patents average 24.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Semnur Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Semnur Pharmaceuticals, Inc.

Q: What technology areas does Semnur Pharmaceuticals, Inc. focus on?

Semnur Pharmaceuticals, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 8 patents. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 2 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Semnur ranks #33,204 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 2 technology areas.

#33,204
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.8/100): 24.6
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R33204 · US Corporation #33,204 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #33,204/49,997
PHOTO-FINISH Security First…
CPC-NARROW A61P · 2 areas
INNOV-THIN 31.8/100
CLAIMS-DENSE 24.6 claims/avg
TYPE-USCORP US Corporation
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Security First Innovations, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
C B Worldwide · near

32
GW Pharma · near

32
Johann Wolfgang… · near

32
Medtentia Internatio… · near

32
Semnur Pharmaceuticals · this assignee

32
3D Lighting… · lowest

7

What this shows Semnur's Innovation Score is 31.8/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Semnur's grants concentrate

Semnur Pharmaceuticals, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). By volume, Semnur sits between Security First Innovations, LLC and Servi-Sure, LLC.

Semnur's three-year grant acceleration

Semnur Pharmaceuticals, Inc. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Security First In…

8
Seda Internationa…

8
Seibersdorf Labor

8
Seibu Electric &…

8
Senecio

8
Sensia Netherland…

8
Serres Oy

8
Servi-sure

8
Semnur Pharmaceut… ◀

8

What this shows Semnur holds 8 patents at rank #33,339, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Semnur

By rank, the assignees closest to #33,339 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Semnur's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Semnur, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (32 here).

Johann Wolfgang Goethe-universitat 32 C.B. Worldwide, Inc. 32 Medtentia International Ltd Oy 32 GW Pharma Ltd. 32

Semnur's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Semnur Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	12.5%
2018	1	12.5%
2019	1	12.5%
2020	1	12.5%
2021	1	12.5%
2022	1	12.5%
2024	1	12.5%
2025partial year	1	12.5%

Which technologies does Semnur Pharmaceuticals, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

Top 2 of 2 technology areas

Where it ranks

Overall rank by patents

#33,204

of 49,997 tracked assignees

Innovation Score

31.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Semnur Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Semnur Pharmaceuticals, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #33,204 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Semnur Pharmaceuticals, Inc. against Security First Innovations, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.